Octenisept Oral Mono (Octenidine Dihydrochloride)

Octenidine dihydrochloride, the active ingredient in Octenisept Oral Mono, is an antiseptic presented as a solution for oral use. It is used to reduce microbial load in the mouth, helping to prevent infection in dental and surgical settings. GNH USA supplies Octenisept Oral Mono as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Octenisept Oral Mono as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Octenisept Oral Mono is an antiseptic that works ​​    ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​ ​ ​  ​    ​     ​    ​         ​ for           ​      ​                                                            ​  ​ ​ ​ ​ ​

- Oral mucosal decontamination: Reduces bacterial and fungal load on oral mucosa. - Pre‑operative preparation: Helps lower infection risk before oral surgery. - Post‑operative care: Supports healing by maintaining a low‑microbial environment after dental procedures.

Octenisept Oral Mono may cause local reactions in the mouth and, rarely, systemic effects.

Common Side Effects: - Taste alteration: Temporary metallic or bitter taste. - Oral irritation: Mild burning or stinging sensation. - Dry mouth: Reduced salivation during use. - Mild erythema: Slight redness of the oral mucosa. - Nausea: Transient feeling of nausea.

Serious or Rare Side Effects: - Allergic reaction: Hives, swelling, or difficulty breathing. - Severe mucosal ulceration: Persistent ulcer formation. - Systemic toxicity: Uncommon but possible signs of systemic absorption. - Anaphylaxis: Acute, life‑threatening hypersensitivity. - Persistent dysphagia: Ongoing difficulty swallowing.

Octenisept              ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​   

- Conduct           ​  ​  ​     ​     ​            ​           ​           ​  ​  ​   ​  ​:      ​     -   -   -   -  -   -   -   -   -   -   -   -    -  \/   t   t  t""""  " " " "  " """ "   " " " " " " " " " " "  " " "  " "  " " " "